MedTrace Logo

Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses

NCT01416272 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2014-11-25

Study results available
· View outcomes & findings →

Summary

The objective of this twelve month dispensing study is to evaluate the clinical performance, particularly comfort and vision, of KeraSoft IC Soft Contact Lenses.

Conditions

  • Keratoconus

Interventions

DEVICE

KeraSoft IC Soft Contact Lenses

Lenses will be worn between 8 and 16 hrs each day, for 12 months

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Robert Steffen, OD, MS · Bausch & Lomb Incorporated

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-12-31
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01416272 on ClinicalTrials.gov